This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Hermès International Société en commandite par actions ( HERM:CA) Shareholder/Analyst Call April 17, 2026 3:30 AM EDT ...

Explore emerging strategies to improve clinical outcomes and slow disease progression in patients with diabetic kidney ...

The White House has submitted to Congress a Fiscal Year 2027 budget request that proposes sweeping changes across the ...

Added top-rated children’s hospitals to QUELIMMUNE™ pediatric Acute Kidney Injury (AKI) customer baseCompleted enrollment in FDA-mandated ...

Discusses KCC2 Deep Dive and Pipeline Advances in CNS Disorders April 14, 2026 9:30 AM EDTCompany ParticipantsMeg Alexander ...

Week Study Evaluates One-Step Dose Titration to 48 mg and Two-Step Dose Titration to 64 mg in Obese Otherwise Healthy Adults CAMBRIDGE, Mass., April 10, 2026 /PRNewswire/ ...

The shareholders of EQT AB (publ) ("EQT") are given notice of the Annual Shareholders' Meeting (the "Meeting") to be held on Tuesday 12 May 2026 at 15.00 CEST at Cirkus, Djurgårdsslätten 43-45, SE-115 ...

Rezatapopt is a first-in-class oral therapy designed to target the TP53 Y220C mutation. This mutation affects the p53 protein ...

Success stories from the Altoona Area School District’s Adult Education Program took centerstage Wednesday during a ...

Iran has asked for a ceasefire, U.S. President Donald Trump says. In a statement on Truth Social today, Trump claimed the request came from “Iran’s New Regime President.” Trump added: “We will ...